Clin Tox DOA committee

Chair: O.Drummer (olaf@vifm.org)
Vice Chair: Vanessa Steenkamp (vanessa.steenkamp@up.ac.za)

Report of recent activities

• The committee last met at the Montreal meeting.
• The clinical toxicology committee set up a working group to produce guidelines on clinical cut-offs for drugs of abuse in cases of child abuse, psychiatric patients and pregnant women.
• The committee established a working party on guidelines for identification using LC-MS(MS) led by Dr Frank Peters.
• The committee commissioned a paper on GHB by Professor Drummer.  A draft has been circulated to committee for review.  Dr André Scholer has written an article on methylphenidate.
• Professor Steven Wong is progressing his work on personalized justice and pharmacogenomics.  Meetings have been held.  The committee is briefed from to time on its activities.
• The committee has been requested to submit ideas for workshops and symposia/roundtables for the Stuttgart meeting next year.
• Dr William Clarke (Baltimore, USA), Dr Gwendolyn McMillin (Utah, USA) and Dr Manuel Neuman (Toronto, Canada) have joined the committee after invitation. 
• The committee chair through the committee will suggest a deputy chair for approval at Executive.

Olaf H Drummer
Chair, Clinical Toxicology/Drugs of Abuse Committee
April, 2010

Minutes of the committee meeting held in Montreal on October 7th, 2009 (PDF): accessible to Members only (committee reports page)

Scientific contributions of the Committee:

• Injectable heroin prescription (PDF file)  NEW

• Six clinical cases used in the Dutch QA Scheme
• "Clinical Toxicology/Drugs of Abuse" : The North American Oxycodone Story 2001-2002
• Therapeutic Drug Monitoring of high-dose buprenorphine: why and how?
• The Effect of Urine Manipulation on Substance Abuse Testing

Terms of reference

To promote and advance the discipline of Clinical Toxicology within the Association by:

1.     Developing relevant practice guidelines, when appropriate, in particular fields of clinical toxicology and drugs of abuse testing;

2.     Publishing articles and other professional notes in the field of clinical toxicology and drugs of abuse in the Newsletter and on the web page;

3.     Assist in the holding of specialist workshops and symposia at the biennial Association meetings;

4.     Developing links and partnerships with other relevant professional societies; and

5.     Attracting new members to the Association with interests in clinical toxicology and drugs of abuse;

Members 

Chair: Professor Dr. Olaf Drummer, olaf@vifm.org

Professor Dr. Albert Fraser, adfraser@dal.ca

Professor Dr. Marilyn A. Huestis, mhuestis@intra.nida.nih.gov

Dr. Saeed A. Jortani, sjortani@Louisville.edu

Dr. Pascal Kintz, pascal.kintz@wanadoo.fr

Professor Dr. Tai C. Kwong, tai_kwong@urmc.rochester.edu

Professor Dr. Hans H. Maurer, hans.maurer@uks.eu  

Dr. Katharina Rentsch, rentsch@ikc.unizh.ch

Dr. André Scholer, ascholer@uhbs.ch

Professor Dr. Donald Uges, d.r.a.uges@apoth.umcg.nl

Professor Dr. Alain Verstraete, Alain.Verstraete@ugent.be  

Professor Dr. Robert Wennig, robert.wennig@uni.lu

Dr. John F. Wilson, heathcontrol@btinternet.com

Professor Dr. Steven Wong, shwong@mcw.edu

Dr Loralie Langman, langman.loralie@mayo.edu 

Dr Vanessa Steenkamp, vanessa.steenkamp@up.ac.za

Dr Frank Peters, frank.peters@med.uni-jena.de

Dr William Clarke, wclarke@jhmi.edu

Dr Gwendolyn McMillin, mcmillga@aruplab.com

Dr Manuela Neuman, manuela.neuman@utoronto.ca